Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2007-11-26
Original market date: See footnote 1
1985-12-31
Product name:
SUFENTA INJ 50MCG/ML
DIN:
01951319 Electronic product monograph is not available
Company:
JANSSEN INC
19 Green Belt Drive
Toronto
Ontario
Canada
M3C 1L9
Class:
Human
Dosage form(s):
Liquid
Route(s) of administration:
Epidural , Intravenous
Number of active ingredient(s):
1
Schedule(s):
Narcotic (CDSA I)
American Hospital Formulary Service (AHFS): See footnote 3
28:08.08
Anatomical Therapeutic Chemical (ATC): See footnote 4
N01AH03 SUFENTANIL
Active ingredient group (AIG) number:See footnote5
0144821001
Active ingredient(s) See footnote8 | Strength |
---|---|
SUFENTANIL (SUFENTANIL CITRATE) | 50 MCG / ML |